(Q34377076)

1 August 2017

1 reference

title

The WHO Vaccine Trial Registry (English)

1 reference

World Health Organization

1 August 2017

0 references

author name string

Robertson SE

1

1 reference

1 August 2017

Mayans MV

2

1 reference

1 August 2017

El-Husseiny A

3

1 reference

1 August 2017

Clemens JD

4

1 reference

1 August 2017

Ivanoff B

5

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

1 August 2017

1 reference

1 August 2017

20

1 reference

1 August 2017

1-2

1 reference

1 August 2017

31-41

1 reference

Registering clinical trials

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Directory of registries of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Vaccine trial data systematically assembled, pooled and disseminated by the Cochrane Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

US launches new clinical trials database

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Epidemiology of enterotoxigenic Escherichia coli diarrhea in a pediatric cohort in a periurban area of lower Egypt

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Early initiation of breastfeeding and the risk of infant diarrhea in rural Egypt

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Measles: immunosuppression, interleukin-12, and complement receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Innate immune responses in children and adults with Shigellosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Functional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Safety and immunogenicity of high-dose Edmonston-Zagreb measles vaccine in children with HIV-1 infection. A cohort study in Kigali, Rwanda.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Changes within T cell receptor V beta subsets in infants following measles vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Immunization of 6 and 9 month old infants with AIK-C, Edmonston-Zagreb, Leningrad-16 and Schwarz strains of measles vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Measles control in Kinshasa, Zaire improved with high coverage and use of medium titre Edmonston Zagreb vaccine at age 6 months

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia. World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Trial of a supplemental dose of four poliovirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Seroresponse to trivalent oral poliovirus vaccine as a function of dosage interval.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Field trial of a locally produced, killed, oral cholera vaccine in Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Safety and immunogenicity of an oral, killed enterotoxigenic Escherichia coli-cholera toxin B subunit vaccine in Egyptian adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Response to conjugate Haemophilus influenzae B vaccine among infants in Niamey, Niger.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

Development of a more thermostable poliovirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900261-4

7 January 2021

10.1016/S0264-410X(01)00261-4

Identifiers

DOI

1 reference

1 August 2017

1 reference